136 related articles for article (PubMed ID: 35634953)
21. Increased Platelet-CD4
Dai XP; Wu FY; Cui C; Liao XJ; Jiao YM; Zhang C; Song JW; Fan X; Zhang JY; He Q; Wang FS
Front Immunol; 2021; 12():799124. PubMed ID: 34987521
[TBL] [Abstract][Full Text] [Related]
22. Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention.
Dalli J; Kitch D; O'Brien MP; Hunt PW; Funderburg N; Moisi D; Gupta A; Brown TT; Tien PC; Aberg JA; Shivakoti R
EBioMedicine; 2023 Mar; 89():104468. PubMed ID: 36791659
[TBL] [Abstract][Full Text] [Related]
23. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
24. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
[TBL] [Abstract][Full Text] [Related]
25. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
[TBL] [Abstract][Full Text] [Related]
26. Impact of Low-level Viremia on Treatment Outcomes During ART - Is it Time to Revise the Definition of Virological Failure?
Poveda E; Crespo M
AIDS Rev; 2018; 20(1):71-72. PubMed ID: 29628513
[TBL] [Abstract][Full Text] [Related]
27. Immunological factors associated with discordant virological response postcombination antiretroviral therapy in pediatric human immunodeficiency virus infection.
Singh R; Maurya SP; Das N; Kabra SK; Lodha R; Das BK
Indian J Pharmacol; 2022; 54(4):278-281. PubMed ID: 36204811
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.
Bai R; Lv S; Hua W; Su B; Wang S; Shao Y; Li Z; Liu A; Sun L; Dai L
HIV Med; 2022 Mar; 23 Suppl 1():72-83. PubMed ID: 35293102
[TBL] [Abstract][Full Text] [Related]
29. Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients.
Lv JN; Li JQ; Cui YB; Ren YY; Fu YJ; Jiang YJ; Shang H; Zhang ZN
Front Immunol; 2021; 12():753044. PubMed ID: 34887859
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART.
Lombardi F; Belmonti S; Rapone L; Borghetti A; Ciccullo A; Gagliardini R; Baldin G; Montagnani F; Moschese D; Emiliozzi A; Rossetti B; De Luca A; Di Giambenedetto S
J Clin Virol; 2018 Jun; 103():57-62. PubMed ID: 29656086
[TBL] [Abstract][Full Text] [Related]
31. Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.
Liang EC; Sceats L; Bayless NL; Strauss-Albee DM; Kubo J; Grant PM; Furman D; Desai M; Katzenstein DA; Davis MM; Zolopa AR; Blish CA
J Virol; 2014 Aug; 88(15):8629-39. PubMed ID: 24850730
[TBL] [Abstract][Full Text] [Related]
32. Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment.
Baroncelli S; Pirillo MF; Tamburrini E; Guaraldi G; Pinnetti C; Degli Antoni A; Galluzzo CM; Stentarelli C; Amici R; Floridia M
AIDS Res Hum Retroviruses; 2015 Jul; 31(7):673-8. PubMed ID: 25769019
[TBL] [Abstract][Full Text] [Related]
33. Association between CD4
Lu D; Zhang JB; Wang YX; Geng ST; Zhang Z; Xu Y; Li SY; Wang KH; Kuang YQ
BMC Infect Dis; 2021 Aug; 21(1):742. PubMed ID: 34344350
[TBL] [Abstract][Full Text] [Related]
34. Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART.
Baldanti F; Paolucci S; Gulminetti R; Maserati R; Migliorino G; Pan A; Maggiolo F; Comolli G; Chiesa A; Gerna G
Antiviral Res; 2001 Jun; 50(3):197-206. PubMed ID: 11397507
[TBL] [Abstract][Full Text] [Related]
35. Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.
Ziani W; Bauer A; Lu H; Wang X; Wu X; Bar KJ; Li H; Liu D; Shaw GM; Veazey RS; Xu H
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568508
[TBL] [Abstract][Full Text] [Related]
36. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of memory B cells and circulating T follicular helper cells is a predictor of poor immune recovery in HIV-infected patients on antiretroviral therapy.
Liu Y; Li Z; Lu X; Kuang YQ; Kong D; Zhang X; Yang X; Wang X; Mu T; Wang H; Zhang Y; Jin J; Xia W; Wu H; Zhang T; Moog C; Su B
J Med Virol; 2023 Feb; 95(2):e28559. PubMed ID: 36755363
[TBL] [Abstract][Full Text] [Related]
38. NKp44L expression on CD4+ T cells is associated with impaired immunological recovery in HIV-infected patients under highly active antiretroviral therapy.
Sennepin A; Baychelier F; Guihot A; Nel I; Ho Tsong Fang R; Calin R; Katlama C; Simon A; Crouzet J; Debré P; Vieillard V
AIDS; 2013 Jul; 27(12):1857-66. PubMed ID: 24179999
[TBL] [Abstract][Full Text] [Related]
39. A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers.
Tomescu C; Liu Q; Ross BN; Yin X; Lynn K; Mounzer KC; Kostman JR; Montaner LJ
PLoS One; 2014; 9(7):e103209. PubMed ID: 25078947
[TBL] [Abstract][Full Text] [Related]
40. T-cell subset distribution in HIV-1-infected patients after 12 years of treatment-induced viremic suppression.
Rönsholt FF; Ullum H; Katzenstein TL; Gerstoft J; Ostrowski SR
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):270-8. PubMed ID: 22614900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
